The ROE as of December 2024 (TTM) for ContraFect Corporation (CFRX) is 376.50%

According to ContraFect Corporation’s latest financial reports and current stock price. The company's current ROE is 376.50%. This represents a change of 66.81% compared to the average of 225.70% of the last 4 quarters.

ContraFect Corporation (CFRX) Historical ROE (quarterly & annually)

How has CFRX ROE performed in the past?

The mean historical ROE of ContraFect Corporation over the last ten years is -96.11%. The current 376.50% ROE has changed -491.74% with respect to the historical average. Over the past ten years (40 quarters), CFRX's ROE was at its highest in in the June 2023 quarter at 683.03%. The ROE was at its lowest in in the June 2022 quarter at -140.39%.

ContraFect Corporation (CFRX) ROE by Quarter and Year

Discovering the peaks and valleys of ContraFect Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ContraFect Corporation (CFRX) Average ROE

How has CFRX ROE performed in the past?

The current ROE of ContraFect Corporation (CFRX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ContraFect Corporation (CFRX) ROE vs. Peers

How is CFRX’s ROE compared to its peers?

ContraFect Corporation’s ROE is less than Palisade Bio, Inc. (0%), greater than Allarity Therapeutics, Inc. (-148.31%), greater than CNS Pharmaceuticals, Inc. (-328.22%), less than Windtree Therapeutics, Inc. (695.91%), greater than Quoin Pharmaceuticals, Ltd. (-115.33%), greater than Revelation Biosciences, Inc. (-126.19%), greater than Virax Biolabs Group Limited (-311.33%), greater than Unicycive Therapeutics, Inc. (-115.10%), greater than NeuroBo Pharmaceuticals, Inc. (-374.14%), greater than Hillstream BioPharma, Inc. (-189.12%), greater than First Wave BioPharma, Inc. (-172.28%), greater than Dermata Therapeutics, Inc. (-17.85%), greater than Panbela Therapeutics, Inc. (-247.40%), less than null (304.71%),

Build a custom stock screener for ContraFect Corporation (CFRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ContraFect Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ContraFect Corporation (CFRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ContraFect Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.